⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9903394 | 1.00 | LMNA (0.36) | — | |
| SCHEMBL28121212 | 0.84 | — | — | |
| SCHEMBL28176962 | 0.84 | — | — | |
| Urea SCHEMBL2288083 | 0.84 | LMNA (0.55) | — | |
| Urea SCHEMBL10965886 | 0.84 | LMNA (0.55) | — | |
| Urea SCHEMBL5915116 | 0.84 | — | — | |
| SCHEMBL4592944 | 0.84 | — | — | |
| Urea SCHEMBL30336008 | 0.84 | LMNA (0.55) | — | |
| SCHEMBL20958648 | 0.81 | CRBN (0.36) | — | |
| SCHEMBL8392893 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4208441-B1 | PROCESS FOR PRODUCING ISOCYANATES | BASF SE (DE) | 2024-06-26 | — | — | EP | disclosed |
| US-20230312462-A1 | PROCESS FOR PRODUCING ISOCYANATES | BASF SE (DE) | 2023-10-05 | — | — | US | disclosed |
| EP-4208441-A1 | PROCESS FOR PRODUCING ISOCYANATES | BASF SE (DE) | 2023-07-12 | — | — | EP | disclosed |
| CN-116034102-A | Process for preparing isocyanates | 巴斯夫欧洲公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-109843952-A | Polyisocyanate composition, blocked polyisocyanate composition, hydrophilic polyisocyanate composition, coating composition and coating film | 旭化成株式会社 | 2019-06-04 | — | — | CN | disclosed |
| CN-109803993-A | polyisocyanate mixture, coating composition and coating film | 旭化成株式会社 | 2019-05-24 | — | — | CN | disclosed |
| CN-109311889-A | Activin receptor-like kinase inhibitors | 蓝图药品公司 | 2019-02-05 | — | — | CN | disclosed |
| EP-2060560-B1 | Preparation of light-colored isocyanates | COVESTRO DEUTSCHLAND AG (DE) | 2016-04-13 | — | — | EP | disclosed |
| US-9024057-B2 | Process for the preparation of isocyanates in the gas phase | BAYER MATERIALSCIENCE AG (DE) | 2015-05-05 | — | — | US | disclosed |
| US-20100152484-A1 | PROCESS FOR THE PREPARATION OF ISOCYANATES IN THE GAS PHASE | BAYER MATERIALSCIENCE AG (DE) | 2010-06-17 | — | — | US | disclosed |
| US-20050075377-A1 | PPAR compounds | PFIZER INC | 2005-04-07 | — | — | US | disclosed |
| US-6699904-B2 | PEROXISOME PROLIFERATOR ACTIVATOR RECEPTOR (PPAR) AGONISTS; ATHEROSCLEROSIS AND CARDIOVASCULAR DISORDERS; FOR EXAMPLE, 3-(4-(2-(3-(2,4-DIMETHOXY-PHENYL)-1-HEPTYL-UREIDO)-ETHYL)-PHENYL)-2-ETHOXY -PROPIONIC ACID | PFIZER INC. | 2004-03-02 | — | — | US | disclosed |
| EP-1372632-A1 | PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS | Pfizer Products Inc. (US) | 2004-01-02 | — | — | EP | disclosed |
| EP-1360172-A1 | PPAR AGONISTS | Pfizer Products Inc. (US) | 2003-11-12 | — | — | EP | disclosed |
| US-20020169192-A1 | PPAR compounds | HAYWARD CHERYL M (US) | 2002-11-14 | — | — | US | disclosed |
| US-20020165282-A1 | Peroxisome proliferator activator receptor (PPAR) agonists; atherosclerosis and cardiovascular disorders; for example, 3-(4-(2-(3-(2,4-dimethoxy-phenyl)-1-heptyl-ureido)-ethyl)-phenyl)-2-ethoxy -propionic acid | HAYWARD CHERYL M (US) | 2002-11-07 | — | — | US | disclosed |
| WO-2002064549-A1 | PPAR AGONISTS | PFIZER PRODUCTS INC. (US) | 2002-08-22 | — | — | WO | disclosed |
| WO-2002064130-A1 | PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS | PFIZER PRODUCTS INC. (US) | 2002-08-22 | — | — | WO | disclosed |
| WO-2000047819-A1 | SIZING DISPERSION | AKZO NOBEL N.V. (NL) | 2000-08-17 | — | — | WO | disclosed |
| US-4230845-A | X-RAY CONTRAST AGENTS | MALLINCKRODT, INC. (US) | 1980-10-28 | — | — | US | disclosed |